Craig Thomas, OD will discuss how he uses the new EyeKinetix(r) as a screening tool to detect subclinical optic neuropathies, including normal tension glaucoma.
You will learn how to integrate this new technology in a busy practice, and review cases that illustrate the importance of accurately detecting subtle pupillary defects.
A Q&A will follow the talk.
*** ODwire.org Raffle *** As usual, we’re also raffling off a prize Register for the event & be entered into our drawing for a new Apple Watch! Hope to see you there!
Allergan, Sightsavers and the International Agency for the Prevention of Blindness (IAPB) today announced a unique joint initiative – ‘Keep Sight’ – to prevent glaucoma-related vision loss by building healthcare capacity in low and middle-income countries with the highest unmet need. The initiative will provide training for healthcare professionals to screen at-risk populations, ensure early and accurate diagnosis and provide appropriate treatment and long-term care in an effort to make a positive impact on people with glaucoma.
The first program is due to launch at a high-volume hospital in Nigeria, where training will be provided for 50 healthcare professionals, with the goal of screening 5,000 people, treating 500 patients and providing surgery for 70 patients. It is anticipated that the initiative will expand to screen 500,000 people in high-burden countries by 2021 and beyond.
Sightsavers CEO, Caroline Harper said: “We are excited to be partnering with Allergan, an organization with a long heritage in eyecare and a shared commitment to drive life-transforming innovations for patients suffering from glaucoma, which is one of the leading causes of irreversible blindness.
“The greatest global needs in eye health today exist in developing countries, where typical barriers include inadequate human resources, poor infrastructure, a lack of awareness and limited access to medical treatments. The partnership between Sightsavers, The IAPB and Allergan is an example of the important and necessary alliances that are needed to fight avoidable blindness and deliver better services to patients.”
“75% of sight loss can be cured or prevented, so it’s an area where donors can have a very real impact, and the partnership will enable us to establish new initiatives in Nigeria. Support from companies like Allergan is really important in our drive to help countries develop their health infrastructure, so this is really great news,” said Harper.
Joanna Conlon, Director of Development and Communications at the International Agency for the Prevention of Blindness, continued: “Glaucoma accounts for between 12% and 16% of blindness in high-income regions, central Asia, parts of Europe and Africaii. Glaucoma in Africa is poised to be a significant public health burden in the coming decade. ‘Keep Sight’ is the kind of solution we need today. IAPB is delighted to be working with Allergan to raise awareness of glaucoma, a ‘neglected’ eye condition.
“Allergan and IAPB had worked together to mark World Glaucoma Week this year, on our very successful ‘Focus On: Glaucoma’ initiative—a series of webinars, blog posts and high-profile lectures–to draw a spotlight on this blinding condition.
“IAPB is delighted to be partnering with Allergan and Sightsavers for ‘Keep Sight’. We will build on the ‘Focus On’ initiative to raise awareness and stimulate policy action so that glaucoma and eye health, in general, are part of universal health coverage.”
“Allergan is honored to partner with Sightsavers and IAPB on ‘Keep Sight’; their wealth of knowledge and expertise, combined with our passion for science and solutions will have a real impact on our shared goal of reducing the high burden of irreversible blindness. For almost two decades Allergan has been committed to developing novel approaches to preserve visual function and prevent blindness caused by glaucoma; ‘Keep Sight’ is an initiative that will make a real difference to people with glaucoma in these underserved populations,” said Marc Princen, Executive Vice President and President, International Commercial at Allergan.
About Sightsavers Sightsavers is an international organization that works in more than 30 developing countries to prevent blindness, restore sight and advocate for social inclusion and equal rights for people with disabilities. It is a registered UK charity (Registered charity numbers 207544 and SC038110) www.sightsavers.org
There are 36 million blind people in the world; 75% of all blindness can be prevented or cured.
In the six decades since its foundation, Sightsavers has:
Supported over 1.1 billion treatments for neglected tropical diseases iii
Carried out over 10.2 million operations to restore sight iii
Trained more than 795,427 primary eye care workers iii
Carried out rehabilitation training for 225,954 blind or low vision beneficiaries iii
Supported 62,908 blind or low vision children to gain a school education iii
About the International Association for the Prevention of Blindness The International Agency for the Prevention of Blindness (IAPB) is the coordinating membership organization leading international efforts in blindness prevention activities. IAPB’s mission is to eliminate the main causes of avoidable blindness and visual impairment by bringing together governments and non-governmental agencies to facilitate the planning, development, and implementation of sustainable national eye care programs. For more information, please visit: https://www.iapb.org/
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system, and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry.
With colleagues and commercial operations located in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.
For more information, visit Allergan’s website at www.Allergan.com.
Learn more at http://curemydisorder.com/links/improve-eyesight-tedmaser-site
In this InSight Studio interview from SECO2019, we speak with Dr. Richard Madonna from SUNY Optometry, where he explains why hypertension is a risk factor for glaucoma. (surprisingly, the answer has part to do with hypotension!)
Glaucoma Surgery Cost Differs From One Country To Another.
The amount of money spent on glaucoma surgery in the USA is about $ 1.56 billion annually. The glaucoma surgery cost is quiet high considering it can only provide a temporary relief. But at least its progression can be suspended or slowed down. A person who has glaucoma will most likely spend more than once for the glaucoma surgery cost and other related treatment as it can recur after the surgery. Glaucoma surgery cost depends on the type of surgery and where your area is. The way to reduce the glaucoma surgery cost is using medication treatment before the surgery is administered.
Medication treatment can help decrease the necessity of administering a surgery because it can make the condition better. In return, the glaucoma surgery cost will be minimized. Medications are prescribed by doctors in order to lower the pressure level in the eye which gradually damages the vision nerve. There are two methods of doing this. One is changing the draining of the fluid in the eye, and the other is increasing the outflow of fluid. When the medications do not work, a person has to undergo a surgery to stop the eye damages being caused by glaucoma. The glaucoma surgery cost is a considerable amount so the patient should be financially prepared before the surgery.
The main purpose of the surgery is to reduce pressure in the eye by increasing the flow of the fluid. Most of the time, the glaucoma surgery cost is high when it is more risky and more complications are involve. Such is the case in closed-angle glaucoma. But operations like open-angle glaucoma surgery are not as expensive because it is not very risky. Although both of these types of surgery aim at increasing the flow of fluid in the eye, their costs are not the same. Aside from the complications involve, Glaucoma surgery cost vary based on your country or area. If you are in India, glaucoma surgery is less costly in comparison to surgery done in USA or other western countries. The difference is caused by the equipment costs which are obviously not the same for every country.
Want to know more about Glaucoma Surgery Cost. Visit Michael Harrah’s page http://glaucomasurgery.org/reports.html now!
While most people are familiar with the term “glaucoma,” not many people know exactly what it is, so what is glaucoma? Glaucoma is a deteriorating vision problem which is caused by excess strain on the eyes. While the cause may sound as if those who have glaucoma are in pain, the truth is that most people who are diagnosed with it do not even know or feel their symptoms. If you are diagnosed with this condition, it can be a frightening experience, mainly due to the fact that the first indications do not show up until it is too late to fix the problem. As soon as vision quality starts to deteriorate, there is no way to reverse its effects.
Tunnel vision and having a narrow line of sight are the first symptoms which manifest themselves. There isn’t much room to improve or repair this, as they rapidly progress to the final stage of glaucoma – blindness.
Doctors believe that glaucoma is caused by bad circulation around the eye sockets, clogged channels, and inadequate drainage of the eyes. These factors are generally caused excess mental stress, eye strain, and high levels of toxins present in the body.
The only “cure” for glaucoma is not really a cure at all, but just medication which is given to relieve the symptoms, but not cure the problem. The medication works to relieve tension and increase drainage from the eyes. Unfortunately, the majority of people diagnosed with glaucoma still become blind. The medicine is given to allow the patient to see a little while longer, adding life to the vision cycle, until blindness eventually sets in.
Because glaucoma is mainly brought on by stress, the stress will not stop once the disease is diagnosed. More often than not, stress levels get higher because many patients are overly concerned by the threat of going blind, which is inevitable. All too often, sufferers of this disease occupy themselves daily with these stressful thoughts and make the symptoms markedly worst.
All patients of glaucoma should receive medical attention as blindness is unavoidable. With this in mind, there are also many things that sufferers can do, taking precautions to cure the symptoms yourself by relaxing the eyes. Each night when you go to sleep, make sure to relax completely before you go to sleep. When you are in bed, close your eyes, and create a mental image of your muscles becoming more relaxed from head to toe. Do your best to try and concentrate especially on the areas and muscles around the eye sockets. By doing this, you will undoubtedly wake up more refreshed, and releasing a lot of pressure which leads to blindness.
While having glaucoma is certainly a scary thing to think about, learning how to put the eyes at ease is the best natural way to cure this vision-threatening condition.
The issues discussed in this article are fully detailed in the Bates Method for Improving Vision Naturally.
